Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib (c) vs everolimus (e) in advanced renal cell carcinoma (rcc) Meeting Abstract
| Authors: | Powles, T.; Motzer, R. J.; George, D. J.; Jonasch, E.; Pal, S.; Tannir, N. M.; Signoretti, S.; Mai, T. H.; Scheffold, C.; Wang, E.; Aftab, D. T.; Escudier, B.; Choueiri, T. K. |
| Abstract Title: | Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib (c) vs everolimus (e) in advanced renal cell carcinoma (rcc) |
| Meeting Title: | 42nd ESMO Congress (ESMO 2017) |
| Journal Title: | Annals of Oncology |
| Volume: | 28 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2017 Sep 8-12 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2017-09-01 |
| Start Page: | mdx371.026 |
| Language: | English |
| ACCESSION: | WOS:000411324002062 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdx371.026 |
| Notes: | Meeting Abstract: 872P -- Appears on pages 307-308 of the abstract book -- Source: Wos |
